Skip to main
NBIX
NBIX logo

Neurocrine Biosciences (NBIX) Market Capitalization Overview

Market Cap: $12.67B as of Jul 1, 2025

$12.67B
Past Month+$492.85M (4.05%)
As of Jul 1, 2025, Neurocrine Biosciences (NBIX) has a market capitalization of $12.67B. Over the past 30 days, its market cap has increased by 2.76%, while in the last 12 months, it has decreased by -8.34%.

Market capitalization represents the total value of Neurocrine Biosciences as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Neurocrine Biosciences (NBIX) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Neurocrine Biosciences (NBIX) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Neurocrine Biosciences (NBIX) Market Cap History

DateMarket CapChange
Jul 1, 2025$12.67B+2.76%
Jun 2, 2025$12.33B+16.89%
May 1, 2025$10.55B-1.15%
Apr 1, 2025$10.67B-6.53%
Mar 3, 2025$11.42B-24.89%
Feb 3, 2025$15.20B+8.88%
Jan 2, 2025$13.96B+9.51%

Neurocrine Biosciences (NBIX) End of Year Market Cap History

DateMarket CapChange
2025$12.67B-8.34%
2024$13.83B+6.76%
2023$12.95B+12.74%
2022$11.49B+42.11%
2021$8.08B-9.78%
2020$8.96B

FAQs About Neurocrine Biosciences (NBIX) Market Cap

As of Jul 1, 2025, the market capitalization of Neurocrine Biosciences (NBIX) is $12.67B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Neurocrine Biosciences’s market capitalization has increased by 4.05%, changing from $12.18B to $12.67B as of Jul 1, 2025.

In the last 3 months, Neurocrine Biosciences’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Neurocrine Biosciences’s market capitalization increased from $12.95B in January to $13.83B in December, reflecting a 6.76% change.

In the past five years, Neurocrine Biosciences (NBIX) has had a compound annual growth rate (CAGR) of 9.07% in market capitalization. This means its market cap has grown at an average rate of 9.07% per year.

Neurocrine Biosciences (NBIX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.